-
Barclays Capital Is Lowering Idenix Pharmaceuticals Inc (IDIX) FY14 Estimate To -0.98 From -0.63
5/1/2013
|
-
Barclays Capital Is Lowering Idenix Pharmaceuticals Inc (IDIX) FY13 Estimate To -0.94 From -0.60
5/1/2013
|
-
Idenix Pharma Posts Q1 Loss Per Share Of $0.23 Vs. Profit $0.10 Year Ago
4/30/2013
|
-
Idenix Pharmaceuticals Presents Detailed Resistance Data From In Vitro Studies
4/24/2013
|
|
|
|
|
-
Barclays Capital Is Raising Idenix Pharmaceuticals Inc (IDIX) FY13 Estimate To -0.60 From -0.85
2/26/2013
|
|
|
-
Idenix Pharma Posts Q4 Loss Per Share Of $.17 Vs. Loss $0.18 Year Ago
2/25/2013
|
|
|